PiroxicamWilliam M. O'Brien, Edward H. Wiseman |
Contents
Chair | 1 |
pharmacology | 11 |
Pharmacokinetic and clinical study of piroxicam | 25 |
Copyright | |
9 other sections not shown
Common terms and phrases
12 Weeks 50 foot walking Academic Press Inc analgesic ankylosing spondylitis aspirin assessment Change from Baseline clinical compared Congress and Symposium corticosteroids decrease discontinued disease dosis double-blind study duration of morning efficacy evaluation fenoprofen fois par jour Geometric Mean grip strength half-life ibuprofen improvement indomethacin joint pain jointly by Academic laboratory malades Medicine International Congress mg/day Mittel morning stiffness naproxen non-steroidal agents non-steroidal anti-inflammatory agent non-steroidal anti-inflammatory drugs NSAID number of painful Number of Patients number of swollen once daily osteoarthritis painful joints parameters patient self-assessment Patienten patients with rheumatoid pharmacokinetic Pharmacology phenylbutazone Piroxicam 20 mg piroxicam therapy Placebo placebo period plasma concentrations prednisone prostaglandin published jointly renal renal papillary necrosis Résumé d'article Rheumatism rheumatoid arthritis Rheumatology Royal Society self-assessment of pain significant Society of Medicine steroid Structure of piroxicam Summarisch sustancias swollen joints Symposium Series Table therapeutic Therapy Figure tolerated tolmetin toxic traitement ulcers Weeks on Therapy Wiseman